Montanova Capital, LLC's Form 4 filing
Benitec Biopharma Inc. (BNTC) · filed Apr 2, 2025
- Accession no.
- 0000899140-25-000486
- Filed
- Apr 2, 2025, 4:37 PM ET
- Trade date
- Mar 31, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 4 non-derivative transactions and 0 derivative transactions. Open-market purchases total $211.7K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Montanova Capital, LLCCIK 0001569064 | Director, 10% Owner |
| Averill Master Fund, Ltd.CIK 0001939329 | Director, 10% Owner |
| Averill Madison Master Fund, Ltd.CIK 0002021243 | Director, 10% Owner |
| Cowen AaronCIK 0001869640 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 31, 2025 | Common stock, par value $0.0001 per share | PPurchaseAcquired | +9,503 | $12.63 | +$120,022.89 | 8,802,748 | Indirect | |
| Mar 31, 2025 | Common stock, par value $0.0001 per share | PPurchaseAcquired | +1,267 | $12.63 | +$16,002.21 | 1,068,031 | Indirect | |
| Mar 31, 2025 | Common stock, par value $0.0001 per share | PPurchaseAcquired | +5,057 | $13.22 | +$66,853.54 | 8,807,805 | Indirect | |
| Mar 31, 2025 | Common stock, par value $0.0001 per share | PPurchaseAcquired | +670 | $13.22 | +$8,857.4 | 1,068,701 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.